{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:13:26Z","timestamp":1783574006304,"version":"3.55.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Transcend Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-traumatic stress disorder (PTSD) is a prevalent and debilitating disorder, and available treatments are limited. TSND-201 (methylone) is in clinical trials for PTSD, showing potential to have rapid, robust and long-lasting benefit without direct agonist\/antagonist activity at 5HT2A. Alterations in structural neuroplasticity are a well-studied mechanism that may underlie both the pathophysiology and treatment of PTSD. Previous work showed that methylone rapidly induced neuroplasticity-related factors in PTSD-relevant brain areas. The current study was undertaken to determine whether methylone affected structural neuroplasticity (e.g., neurite outgrowth) and whether its effects may also be long-lasting. Methylone stimulated neurite outgrowth, specifically increasing the number of branches and the length of the longest neurite per cell in cultured cortical neurons. Methylone\u2019s effect on neurite branching was blocked by inhibitors of monoamine transporters (reboxetine, escitalopram, JHW-007) whereas its effects on the length of the longest neurite per cell were mediated by trkB receptors or mTor signaling. RNA-seq and functional enrichment analyses suggest that methylone has long-lasting effects on factors that mediate neurite outgrowth. Rapid and long-lasting effects of methylone on fear extinction learning and memory were also observed, consistent with the rapid and long-lasting neuroplasticity effects. Reboxetine blocked methylone\u2019s improvement of extinction recall memory, suggesting NET activity is required for methylone\u2019s behavioral effect. Together, this work provides insight into methylone\u2019s mechanism of action and evidence that rapid-acting pharmacotherapies that induce structural neuroplasticity may have potential to treat PTSD.<\/jats:p>","DOI":"10.1038\/s41386-025-02206-z","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T10:11:43Z","timestamp":1755943903000},"page":"631-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Methylone promotes neurite outgrowth and has long-lasting effects on fear extinction learning"],"prefix":"10.1038","volume":"51","author":[{"given":"Jennifer","family":"Warner-Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stogniew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kelmendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"2206_CR1","doi-asserted-by":"publisher","first-page":"1353383","DOI":"10.1080\/20008198.2017.1353383","volume":"8","author":"RC Kessler","year":"2017","unstructured":"Kessler RC, Aguilar-Gaxiola S, Alonso J, Benjet C, Bromet EJ, Cardoso G, et al. Trauma and PTSD in the WHO World Mental Health Surveys. Eur J Psychotraumatol. 2017;8:1353383.","journal-title":"Eur J Psychotraumatol"},{"key":"2206_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41582-022-00635-8","volume":"18","author":"KJ Ressler","year":"2022","unstructured":"Ressler KJ, Berretta S, Bolshakov VY, Rosso IM, Meloni EG, Rauch SL, et al. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat Rev Neurol. 2022;18:273\u201388.","journal-title":"Nat Rev Neurol"},{"key":"2206_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neulet.2017.04.046","volume":"649","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Southwick SM, Krystal JH. Neurobiology of posttraumatic stress disorder (PTSD): a path from novel pathophysiology to innovative therapeutics. Neurosci Lett. 2017;649:130\u20132.","journal-title":"Neurosci Lett"},{"key":"2206_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1017\/S1461145711001209","volume":"15","author":"JC Ipser","year":"2012","unstructured":"Ipser JC, Stein DJ. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012;15:825\u201340.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2206_CR5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1080\/13854040903277289","volume":"23","author":"TW McAllister","year":"2009","unstructured":"McAllister TW. Psychopharmacological issues in the treatment of TBI and PTSD. Clin Neuropsychol. 2009;23:1338\u201367.","journal-title":"Clin Neuropsychol"},{"key":"2206_CR6","first-page":"2519","volume":"8","author":"LA Averill","year":"2023","unstructured":"Averill LA, Perelman M, Ching THW, Farre M, Mandell B, Stogniew M, et al. A case series providing clinical evidence that Methylone produces rapid and robust improvements in major depressive disorder. Ann Clin Case Rep. 2023;8:2519.","journal-title":"Ann Clin Case Rep"},{"key":"2206_CR7","unstructured":"Jones, A, Warner-Schmidt, J, Stogniew, M, Mandell, B, Kwak, H, and Miller, PW, Methylone for the treatment of PTSD: initial results from an open-label study (IMPACT-1), Tampa, FL: ACNP; 2023."},{"key":"2206_CR8","doi-asserted-by":"crossref","unstructured":"Poyatos L, Lo Faro AF, Berardinelli D, Sprega G, Malaca S, Pichini S, et al. Methylone and MDMA pharmacokinetics following controlled administration in humans. Int J Mol Sci. 2022;23:14636.","DOI":"10.3390\/ijms232314636"},{"key":"2206_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/biology10080788","volume":"10","author":"L Poyatos","year":"2021","unstructured":"Poyatos L, Papaseit E, Olesti E, P\u00e9rez-Ma\u00f1\u00e1 C, Ventura M, Carb\u00f3n X, et al. A comparison of acute pharmacological effects of methylone and MDMA administration in humans and oral fluid concentrations as biomarkers of exposure. Biology. 2021;10:788.","journal-title":"Biology"},{"key":"2206_CR10","doi-asserted-by":"publisher","first-page":"1122861","DOI":"10.3389\/fphar.2023.1122861","volume":"14","author":"L Poyatos","year":"2023","unstructured":"Poyatos L, P\u00e9rez-Ma\u00f1\u00e1 C, Hladun O, N\u00fa\u00f1ez-Montero M, de la Rosa G, Mart\u00edn S, et al. Pharmacological effects of methylone and MDMA in humans. Front Pharmacol. 2023;14:1122861.","journal-title":"Front Pharmacol"},{"key":"2206_CR11","unstructured":"Jones, A, Warner-Schmidt, J, Kwak, H, Stogniew, M, Mandell, B, Ching, THW, et al., Efficacy and safety of the neuroplastogen TSND-201 (methylone) for the treatment of PTSD: A phase 2 randomized controlled trial. JAMA Psychiatry, 2025. under review."},{"key":"2206_CR12","doi-asserted-by":"publisher","first-page":"109787","DOI":"10.1016\/j.neuropharm.2023.109787","volume":"242","author":"Z Li","year":"2024","unstructured":"Li Z, Peng HY, Lee CS, Lin TB, Hsieh MC, Lai CY, et al. Methylone produces antidepressant-relevant actions and prosocial effects. Neuropharmacology. 2024;242:109787.","journal-title":"Neuropharmacology"},{"key":"2206_CR13","doi-asserted-by":"publisher","first-page":"1041277","DOI":"10.3389\/fpsyt.2022.1041277","volume":"13","author":"J Warner-Schmidt","year":"2022","unstructured":"Warner-Schmidt J, Pittenger C, Stogniew M, Mandell B, Olmstead SJ, Kelmendi B. Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity. Front Psychiatry. 2022;13:1041277.","journal-title":"Front Psychiatry"},{"key":"2206_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fpsyt.2017.00232","volume":"8","author":"K \u0160tefkov\u00e1","year":"2017","unstructured":"\u0160tefkov\u00e1 K, \u017didkov\u00e1 M, Horsley RR, Pinterov\u00e1 N, \u0160\u00edchov\u00e1 K, Uttl L, et al. Pharmacokinetic, ambulatory, and hyperthermic effects of 3,4-methylenedioxy-N-Methylcathinone (Methylone) in rats. Front Psychiatry. 2017;8:232.","journal-title":"Front Psychiatry"},{"key":"2206_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley P, et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology. 2012;37:1192\u2013203.","journal-title":"Neuropsychopharmacology"},{"key":"2206_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A. Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol. 2013;85:1803\u201315.","journal-title":"Biochem Pharmacol"},{"key":"2206_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.116.236349","volume":"360","author":"AJ Eshleman","year":"2017","unstructured":"Eshleman AJ, Wolfrum KM, Reed JF, Kim SO, Swanson T, Johnson RA, et al. Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release. J Pharmacol Exp Ther. 2017;360:33\u201347.","journal-title":"J Pharmacol Exp Ther"},{"key":"2206_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","volume":"167","author":"R L\u00f3pez-Arnau","year":"2012","unstructured":"L\u00f3pez-Arnau R, Mart\u00ednez-Clemente J, Pubill D, Escubedo E, Camarasa J. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol. 2012;167:407\u201320.","journal-title":"Br J Pharmacol"},{"key":"2206_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1177\/0269881119844185","volume":"33","author":"D Luethi","year":"2019","unstructured":"Luethi D, Kolaczynska KE, Walter M, Suzuki M, Rice KC, Blough BE, et al. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems. J Psychopharmacol. 2019;33:831\u201341.","journal-title":"J Psychopharmacol"},{"key":"2206_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013;168:458\u201370.","journal-title":"Br J Pharmacol"},{"key":"2206_CR21","doi-asserted-by":"publisher","first-page":"1353131","DOI":"10.3389\/fnins.2024.1353131","volume":"18","author":"J Warner-Schmidt","year":"2024","unstructured":"Warner-Schmidt J, Stogniew M, Mandell B, Rowland RS, Schmidt EF, Kelmendi B. Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA. Front Neurosci. 2024;18:1353131.","journal-title":"Front Neurosci"},{"key":"2206_CR22","doi-asserted-by":"publisher","first-page":"111201","DOI":"10.1016\/j.pnpbp.2024.111201","volume":"136","author":"D Chou","year":"2025","unstructured":"Chou D, Peng HY, Lin TB, Hsieh MC, Lai CY, Lee CS. Methylone regulates fear memory and amygdala activity: A potential treatment for posttraumatic stress disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2025;136:111201.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2206_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ynstr.2014.10.002","volume":"1","author":"AF Arnsten","year":"2015","unstructured":"Arnsten AF, Raskind MA, Taylor FB, Connor DF. The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder. Neurobiol Stress. 2015;1:89\u201399.","journal-title":"Neurobiol Stress"},{"key":"2206_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ejn.14630","volume":"53","author":"RS Duman","year":"2021","unstructured":"Duman RS, Deyama S, Fogaca MV. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants. Eur J Neurosci. 2021;53:126\u201339.","journal-title":"Eur J Neurosci"},{"key":"2206_CR25","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170\u201382.","journal-title":"Cell Rep"},{"key":"2206_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuron.2013.06.028","volume":"79","author":"BS McEwen","year":"2013","unstructured":"McEwen BS, Morrison JH. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron. 2013;79:16\u201329.","journal-title":"Neuron"},{"key":"2206_CR27","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","volume":"16","author":"M Nibuya","year":"1996","unstructured":"Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 1996;16:2365\u201372.","journal-title":"J Neurosci"},{"key":"2206_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3379","volume":"14","author":"H Park","year":"2013","unstructured":"Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14:7\u201323.","journal-title":"Nat Rev Neurosci"},{"key":"2206_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27:1025\u201333.","journal-title":"Nat Med"},{"key":"2206_CR30","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","volume":"29","author":"JM Mitchell","year":"2023","unstructured":"Mitchell JM, Ot'alora G M, van der Kolk B, Shannon S, Bogenschutz M, Gelfand Y, et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nat Med. 2023;29:2473\u201380.","journal-title":"Nat Med"},{"key":"2206_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41583-024-00876-0","volume":"26","author":"C Liao","year":"2025","unstructured":"Liao C, Dua AN, Wojtasiewicz C, Liston C, Kwan AC. Structural neural plasticity evoked by rapid-acting antidepressant interventions. Nat Rev Neurosci. 2025;26:101\u201314.","journal-title":"Nat Rev Neurosci"},{"key":"2206_CR32","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"LX Shao","year":"2021","unstructured":"Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron. 2021;109:2535\u20132544 e4.","journal-title":"Neuron"},{"key":"2206_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuropharm.2013.11.019","volume":"79","author":"MK Seo","year":"2014","unstructured":"Seo MK, Lee CH, Cho HY, Lee JG, Lee BJ, Kim JE, et al. Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures. Neuropharmacology. 2014;79:222\u201333.","journal-title":"Neuropharmacology"},{"key":"2206_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"2206_CR35","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1038\/tp.2015.138","volume":"5","author":"MB Young","year":"2015","unstructured":"Young MB, Andero R, Ressler KJ, Howell LL. 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning. Transl Psychiatry. 2015;5:e634\u2013e634.","journal-title":"Transl Psychiatry"},{"key":"2206_CR36","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1523\/JNEUROSCI.18-08-02808.1998","volume":"18","author":"JP Fawcett","year":"1998","unstructured":"Fawcett JP, Bamji SX, Causing CG, Aloyz R, Ase AR, Reader TA, et al. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci. 1998;18:2808\u201321.","journal-title":"J Neurosci"},{"key":"2206_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0091-3057(03)00044-3","volume":"75","author":"AS Ivy","year":"2003","unstructured":"Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav. 2003;75:81\u20138.","journal-title":"Pharmacol Biochem Behav"},{"key":"2206_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.brainres.2006.06.008","volume":"1108","author":"DM Juric","year":"2006","unstructured":"Juric DM, Miklic S, Carman-Krzan M. Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes. Brain Res. 2006;1108:54\u201362.","journal-title":"Brain Res"},{"key":"2206_CR39","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell. 2021;184:1299\u20131313 e19.","journal-title":"Cell"},{"key":"2206_CR40","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","volume":"26","author":"R Moliner","year":"2023","unstructured":"Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci. 2023;26:1032\u201341.","journal-title":"Nat Neurosci"},{"key":"2206_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0829-z","volume":"19","author":"JH Krystal","year":"2017","unstructured":"Krystal JH, Abdallah CG, Averill LA, Kelmendi B, Harpaz-Rotem I, Sanacora G, et al. Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Curr Psychiatry Rep. 2017;19:74.","journal-title":"Curr Psychiatry Rep"},{"key":"2206_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","volume":"90","author":"E Castren","year":"2021","unstructured":"Castren E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry. 2021;90:128\u201336.","journal-title":"Biol Psychiatry"},{"key":"2206_CR43","doi-asserted-by":"publisher","first-page":"1356563","DOI":"10.3389\/fpsyt.2024.1356563","volume":"15","author":"LL Davis","year":"2024","unstructured":"Davis LL, Hamner MB. Post-traumatic stress disorder: the role of the amygdala and potential therapeutic interventions - a review. Front Psychiatry. 2024;15:1356563.","journal-title":"Front Psychiatry"},{"key":"2206_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/1073858409333072","volume":"15","author":"M Koenigs","year":"2009","unstructured":"Koenigs M, Grafman J. Posttraumatic stress disorder: the role of medial prefrontal cortex and amygdala. Neuroscientist. 2009;15:540\u20138.","journal-title":"Neuroscientist"},{"key":"2206_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/dneu.22207","volume":"75","author":"FW Flynn","year":"2015","unstructured":"Flynn FW, Kinney-Lang E, Hoekstra C, Pratt DL, Thakar A. Activation of the neurokinin 3 receptor promotes filopodia growth and sprouting in rat embryonic hypothalamic cells. Dev Neurobiol. 2015;75:12\u201322.","journal-title":"Dev Neurobiol"},{"key":"2206_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48519-0","volume":"9","author":"LP Croteau","year":"2019","unstructured":"Croteau LP, Kao TJ, Kania A. Ephrin-A5 potentiates netrin-1 axon guidance by enhancing Neogenin availability. Sci Rep. 2019;9:12009.","journal-title":"Sci Rep"},{"key":"2206_CR47","doi-asserted-by":"publisher","first-page":"e3002044","DOI":"10.1371\/journal.pbio.3002044","volume":"21","author":"C Decourt","year":"2023","unstructured":"Decourt C, Schaeffer J, Blot B, Paccard A, Excoffier B, Pende M, et al. The RSK2-RPS6 axis promotes axonal regeneration in the peripheral and central nervous systems. PLoS Biol. 2023;21:e3002044.","journal-title":"PLoS Biol"},{"key":"2206_CR48","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.4103\/1673-5374.215268","volume":"12","author":"Y Zou","year":"2017","unstructured":"Zou Y, Zhang WF, Liu HY, Li X, Zhang X, Ma XF, et al. Structure and function of the contactin-associated protein family in myelinated axons and their relationship with nerve diseases. Neural Regen Res. 2017;12:1551\u20138.","journal-title":"Neural Regen Res"},{"key":"2206_CR49","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nrn4023","volume":"16","author":"RD Fields","year":"2015","unstructured":"Fields RD. A new mechanism of nervous system plasticity: activity-dependent myelination. Nat Rev Neurosci. 2015;16:756\u201367.","journal-title":"Nat Rev Neurosci"},{"key":"2206_CR50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41582-022-00737-3","volume":"18","author":"JK Knowles","year":"2022","unstructured":"Knowles JK, Batra A, Xu H, Monje M. Adaptive and maladaptive myelination in health and disease. Nat Rev Neurol. 2022;18:735\u201346.","journal-title":"Nat Rev Neurol"},{"key":"2206_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01745-5","volume":"11","author":"KLP Long","year":"2021","unstructured":"Long KLP, Chao LL, Kazama Y, An A, Hu KY, Peretz L, et al. Regional gray matter oligodendrocyte- and myelin-related measures are associated with differential susceptibility to stress-induced behavior in rats and humans. Transl Psychiatry. 2021;11:631.","journal-title":"Transl Psychiatry"},{"key":"2206_CR52","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/ijms20081999","volume":"20","author":"R P\u00e9rez-Sen","year":"2019","unstructured":"P\u00e9rez-Sen R, Queipo MJ, Gil-Redondo JC, Ortega F, G\u00f3mez-Villafuertes R, Miras-Portugal MT, et al. Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells. Int J Mol Sci. 2019;20:1999.","journal-title":"Int J Mol Sci"},{"key":"2206_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neuroscience.2012.09.017","volume":"239","author":"F Jeanneteau","year":"2013","unstructured":"Jeanneteau F, Chao MV. Are BDNF and glucocorticoid activities calibrated? Neuroscience. 2013;239:173\u201395.","journal-title":"Neuroscience"},{"key":"2206_CR54","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/npp.2011.331","volume":"37","author":"A Menke","year":"2012","unstructured":"Menke A, Arloth J, P\u00fctz B, Weber P, Klengel T, Mehta D, et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology. 2012;37:1455\u201364.","journal-title":"Neuropsychopharmacology"},{"key":"2206_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2015.07.005","volume":"99","author":"V Vialou","year":"2015","unstructured":"Vialou V, Thibault M, Kaska S, Cooper S, Gajewski P, Eagle A, et al. Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress. Neuropharmacology. 2015;99:28\u201337.","journal-title":"Neuropharmacology"},{"key":"2206_CR56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.molbrainres.2004.05.014","volume":"132","author":"CA McClung","year":"2004","unstructured":"McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ, et al. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res. 2004;132:146\u201354.","journal-title":"Brain Res Mol Brain Res"},{"key":"2206_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/neuro.01.002.2008","volume":"2","author":"R Poirier","year":"2008","unstructured":"Poirier R, Cheval H, Mailhes C, Garel S, Charnay P, Davis S, et al. Distinct functions of egr gene family members in cognitive processes. Front Neurosci. 2008;2:47\u201355.","journal-title":"Front Neurosci"},{"key":"2206_CR58","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.tins.2016.02.003","volume":"39","author":"X Sun","year":"2016","unstructured":"Sun X, Lin Y. Npas4: linking neuronal activity to memory. Trends Neurosci. 2016;39:264\u201375.","journal-title":"Trends Neurosci"},{"key":"2206_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuron.2014.05.027","volume":"83","author":"Y Chen","year":"2014","unstructured":"Chen Y, Wang Y, Ert\u00fcrk A, Kallop D, Jiang Z, Weimer RM, et al. Activity-induced Nr4a1 regulates spine density and distribution pattern of excitatory synapses in pyramidal neurons. Neuron. 2014;83:431\u201343.","journal-title":"Neuron"},{"key":"2206_CR60","doi-asserted-by":"publisher","first-page":"108753","DOI":"10.1016\/j.celrep.2021.108753","volume":"34","author":"HM Belalcazar","year":"2021","unstructured":"Belalcazar HM, Hendricks EL, Zamurrad S, Liebl F, Secombe J. The histone demethylase KDM5 is required for synaptic structure and function at the Drosophila neuromuscular junction. Cell Rep. 2021;34:108753.","journal-title":"Cell Rep"},{"key":"2206_CR61","first-page":"78","volume":"8","author":"K Minatohara","year":"2015","unstructured":"Minatohara K, Akiyoshi M, Okuno H. Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace. Front Mol Neurosci. 2015;8:78.","journal-title":"Front Mol Neurosci"},{"key":"2206_CR62","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.dib.2018.08.198","volume":"20","author":"TJ Akiki","year":"2018","unstructured":"Akiki TJ, Averill CL, Wrocklage KM, Scott JC, Averill LA, Schweinsburg B, et al. Topology of brain functional connectivity networks in posttraumatic stress disorder. Data Brief. 2018;20:1658\u201375.","journal-title":"Data Brief"},{"key":"2206_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.psychres.2019.02.005","volume":"277","author":"PR Szeszko","year":"2019","unstructured":"Szeszko PR, Yehuda R. Magnetic resonance imaging predictors of psychotherapy treatment response in post-traumatic stress disorder: A role for the salience network. Psychiatry Res. 2019;277:52\u201357.","journal-title":"Psychiatry Res"},{"key":"2206_CR64","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1523\/JNEUROSCI.4603-15.2016","volume":"36","author":"HH Chen","year":"2016","unstructured":"Chen HH, Yu HI, Tarn WY. DDX3 modulates neurite development via translationally activating an RNA regulon involved in Rac1 activation. J Neurosci. 2016;36:9792\u2013804.","journal-title":"J Neurosci"},{"key":"2206_CR65","doi-asserted-by":"publisher","first-page":"669798","DOI":"10.3389\/fcell.2021.669798","volume":"9","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhou Y, Jiang Y, Lu Z, Xiao X, Ning J, et al. Profiling of sexually dimorphic genes in neural cells to identify Eif2s3y, whose overexpression causes autism-like behaviors in male mice. Front Cell Dev Biol. 2021;9:669798.","journal-title":"Front Cell Dev Biol"},{"key":"2206_CR66","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/emboj\/18.8.2196","volume":"18","author":"T Ohtsuka","year":"1999","unstructured":"Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J. 1999;18:2196\u2013207.","journal-title":"EMBO J"},{"key":"2206_CR67","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.1523\/JNEUROSCI.2417-11.2011","volume":"31","author":"X Li","year":"2011","unstructured":"Li X, Masliah E, Reixach N, Buxbaum JN. Neuronal production of transthyretin in human and murine Alzheimer\u2019s disease: is it protective? J Neurosci. 2011;31:12483\u201390.","journal-title":"J Neurosci"},{"key":"2206_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2174\/187152707783220929","volume":"6","author":"M Banasr","year":"2007","unstructured":"Banasr M, Duman RS. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets. 2007;6:311\u201320.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2206_CR69","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1176\/appi.ajp.2018.17121368","volume":"176","author":"S Deyama","year":"2019","unstructured":"Deyama S, Bang E, Wohleb ES, Li XY, Kato T, Gerhard DM, et al. Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine. Am J Psychiatry. 2019;176:388\u2013400.","journal-title":"Am J Psychiatry"},{"key":"2206_CR70","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1073\/pnas.0610282104","volume":"104","author":"JL Warner-Schmidt","year":"2007","unstructured":"Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA. 2007;104:4647\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2206_CR71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neubiorev.2016.08.023","volume":"71","author":"MBL Careaga","year":"2016","unstructured":"Careaga MBL, Girardi CEN, Suchecki D. Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation. Neurosci Biobehav Rev. 2016;71:48\u201357.","journal-title":"Neurosci Biobehav Rev"},{"key":"2206_CR72","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1038\/s41380-025-02910-8","volume":"30","author":"R Andero","year":"2025","unstructured":"Andero R. Stress-induced changes in the molecular processes underlying fear memories: implications for PTSD and relevant animal models. Mol Psychiatry. 2025;30:2219\u201327.","journal-title":"Mol Psychiatry"},{"key":"2206_CR73","doi-asserted-by":"publisher","first-page":"1546460","DOI":"10.3389\/fnins.2025.1546460","volume":"19","author":"M Boese","year":"2025","unstructured":"Boese M, Berman R, Radford K, Johnson LR, Choi K. Effects of ketamine on fear memory extinction: a review of preclinical literature. Front Neurosci. 2025;19:1546460.","journal-title":"Front Neurosci"},{"key":"2206_CR74","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s40265-024-02106-4","volume":"84","author":"MK Doss","year":"2024","unstructured":"Doss MK, DeMarco A, Dunsmoor JE, Cisler JM, Fonzo GA, Nemeroff CB. How psychedelics modulate multiple memory mechanisms in posttraumatic stress disorder. Drugs. 2024;84:1419\u201343.","journal-title":"Drugs"},{"key":"2206_CR75","doi-asserted-by":"publisher","first-page":"105983","DOI":"10.1016\/j.neubiorev.2024.105983","volume":"169","author":"FM Kausche","year":"2025","unstructured":"Kausche FM, Carsten HP, Sobania KM, Riesel A. Fear and safety learning in anxiety- and stress-related disorders: An updated meta-analysis. Neurosci Biobehav Rev. 2025;169:105983.","journal-title":"Neurosci Biobehav Rev"},{"key":"2206_CR76","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0006-8993(79)90043-X","volume":"165","author":"ST Mason","year":"1979","unstructured":"Mason ST, Fibiger H. Noradrenaline, fear and extinction. Brain Res. 1979;165:47\u201356.","journal-title":"Brain Res"},{"key":"2206_CR77","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0006-8993(82)90806-X","volume":"245","author":"DA McCormick","year":"1982","unstructured":"McCormick DA, Thompson RF. Locus coeruleus lesions and resistance to extinction of a classically conditioned response: involvement of the neocortex and hippocampus. Brain Res. 1982;245:239\u201349.","journal-title":"Brain Res"},{"key":"2206_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.287.5451.248","volume":"287","author":"JL McGaugh","year":"2000","unstructured":"McGaugh JL. Memory-a century of consolidation. Science. 2000;287:248\u201351.","journal-title":"Science"},{"key":"2206_CR79","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1523\/JNEUROSCI.3248-07.2008","volume":"28","author":"D Mueller","year":"2008","unstructured":"Mueller D, Porter JT, Quirk GJ. Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci. 2008;28:369\u201375.","journal-title":"J Neurosci"},{"key":"2206_CR80","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1007\/s00213-017-4684-8","volume":"234","author":"MB Young","year":"2017","unstructured":"Young MB, Norrholm SD, Khoury LM, Jovanovic T, Rauch S, Reiff CM, et al. Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). Psychopharmacology. 2017;234:2883\u201395.","journal-title":"Psychopharmacology"},{"key":"2206_CR81","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00213-023-06333-7","volume":"240","author":"EJ Heesbeen","year":"2023","unstructured":"Heesbeen EJ, Bijlsma EY, Verdouw PM, van Lissa C, Hooijmans C, Groenink L. The effect of SSRIs on fear learning: a systematic review and meta-analysis. Psychopharmacology. 2023;240:2335\u201359.","journal-title":"Psychopharmacology"},{"key":"2206_CR82","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1021\/acschemneuro.4c00279","volume":"15","author":"SC Woodburn","year":"2024","unstructured":"Woodburn SC, Levitt CM, Koester AM, Kwan AC. Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors. ACS Chem Neurosci. 2024;15:3034\u201343.","journal-title":"ACS Chem Neurosci"},{"key":"2206_CR83","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349.","journal-title":"Nat Med"},{"key":"2206_CR84","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.neuropharm.2008.06.062","volume":"55","author":"JW Lipton","year":"2008","unstructured":"Lipton JW, Tolod EG, Thompson VB, Pei L, Paumier KL, Terpstra BT, et al. 3,4-methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture. Neuropharmacology. 2008;55:851\u20139.","journal-title":"Neuropharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02206-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02206-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02206-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:03:24Z","timestamp":1769036604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02206-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2206"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02206-z","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JW-S, MS, and BM are full-time employees with equity at Transcend Therapeutics. BK is a consultant with equity at Transcend Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}